nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenelzine—CYP2E1—Dacarbazine—pancreatic cancer	0.0751	0.0839	CbGbCtD
Phenelzine—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0619	0.0692	CbGbCtD
Phenelzine—CYP3A7—Tamoxifen—pancreatic cancer	0.0619	0.0692	CbGbCtD
Phenelzine—CYP2E1—Tamoxifen—pancreatic cancer	0.0597	0.0668	CbGbCtD
Phenelzine—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0475	0.0531	CbGbCtD
Phenelzine—CYP3A7—Irinotecan—pancreatic cancer	0.0475	0.0531	CbGbCtD
Phenelzine—CYP3A5—Tamoxifen—pancreatic cancer	0.0464	0.0519	CbGbCtD
Phenelzine—CYP2C8—Tamoxifen—pancreatic cancer	0.0446	0.0499	CbGbCtD
Phenelzine—CYP3A5—Erlotinib—pancreatic cancer	0.0395	0.0441	CbGbCtD
Phenelzine—CYP2C8—Erlotinib—pancreatic cancer	0.0379	0.0424	CbGbCtD
Phenelzine—CYP2C19—Tamoxifen—pancreatic cancer	0.0374	0.0419	CbGbCtD
Phenelzine—CYP3A5—Irinotecan—pancreatic cancer	0.0356	0.0398	CbGbCtD
Phenelzine—CYP3A7—Docetaxel—pancreatic cancer	0.0348	0.0389	CbGbCtD
Phenelzine—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0348	0.0389	CbGbCtD
Phenelzine—CYP3A7—Sunitinib—pancreatic cancer	0.0347	0.0388	CbGbCtD
Phenelzine—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0347	0.0388	CbGbCtD
Phenelzine—CYP2C8—Fluorouracil—pancreatic cancer	0.0329	0.0368	CbGbCtD
Phenelzine—CYP3A5—Docetaxel—pancreatic cancer	0.0261	0.0292	CbGbCtD
Phenelzine—CYP3A5—Sunitinib—pancreatic cancer	0.026	0.0291	CbGbCtD
Phenelzine—CYP3A4—Tamoxifen—pancreatic cancer	0.0181	0.0202	CbGbCtD
Phenelzine—CYP3A4—Erlotinib—pancreatic cancer	0.0154	0.0172	CbGbCtD
Phenelzine—CYP3A4—Irinotecan—pancreatic cancer	0.0139	0.0155	CbGbCtD
Phenelzine—CYP3A4—Docetaxel—pancreatic cancer	0.0102	0.0114	CbGbCtD
Phenelzine—CYP3A4—Sunitinib—pancreatic cancer	0.0101	0.0113	CbGbCtD
Phenelzine—CYP3A4—Doxorubicin—pancreatic cancer	0.00759	0.00849	CbGbCtD
Phenelzine—Hepatocellular injury—Tamoxifen—pancreatic cancer	0.00174	0.0165	CcSEcCtD
Phenelzine—Hepatocellular injury—Erlotinib—pancreatic cancer	0.00172	0.0163	CcSEcCtD
Phenelzine—Nystagmus—Fluorouracil—pancreatic cancer	0.00165	0.0156	CcSEcCtD
Phenelzine—Hypernatraemia—Epirubicin—pancreatic cancer	0.00109	0.0103	CcSEcCtD
Phenelzine—Coma—Fluorouracil—pancreatic cancer	0.00107	0.0102	CcSEcCtD
Phenelzine—Euphoric mood—Fluorouracil—pancreatic cancer	0.00101	0.00957	CcSEcCtD
Phenelzine—Hypernatraemia—Doxorubicin—pancreatic cancer	0.00101	0.00955	CcSEcCtD
Phenelzine—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.00101	0.00953	CcSEcCtD
Phenelzine—Weight increased—Tamoxifen—pancreatic cancer	0.000994	0.00942	CcSEcCtD
Phenelzine—Sweating—Tamoxifen—pancreatic cancer	0.000934	0.00884	CcSEcCtD
Phenelzine—Hepatocellular injury—Docetaxel—pancreatic cancer	0.000849	0.00804	CcSEcCtD
Phenelzine—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.000814	0.00771	CcSEcCtD
Phenelzine—Ataxia—Fluorouracil—pancreatic cancer	0.000803	0.00761	CcSEcCtD
Phenelzine—Nystagmus—Epirubicin—pancreatic cancer	0.000802	0.00759	CcSEcCtD
Phenelzine—Nystagmus—Doxorubicin—pancreatic cancer	0.000742	0.00703	CcSEcCtD
Phenelzine—Leukopenia—Tamoxifen—pancreatic cancer	0.000681	0.00645	CcSEcCtD
Phenelzine—Liver injury—Epirubicin—pancreatic cancer	0.000681	0.00645	CcSEcCtD
Phenelzine—Jaundice—Irinotecan—pancreatic cancer	0.00067	0.00634	CcSEcCtD
Phenelzine—Delirium—Epirubicin—pancreatic cancer	0.000666	0.00631	CcSEcCtD
Phenelzine—Sweating—Irinotecan—pancreatic cancer	0.000659	0.00624	CcSEcCtD
Phenelzine—Anxiety—Tamoxifen—pancreatic cancer	0.000646	0.00612	CcSEcCtD
Phenelzine—Sweating—Gemcitabine—pancreatic cancer	0.000642	0.00608	CcSEcCtD
Phenelzine—Discomfort—Tamoxifen—pancreatic cancer	0.00064	0.00606	CcSEcCtD
Phenelzine—Anxiety—Erlotinib—pancreatic cancer	0.000639	0.00605	CcSEcCtD
Phenelzine—Dry mouth—Tamoxifen—pancreatic cancer	0.000634	0.006	CcSEcCtD
Phenelzine—Liver injury—Doxorubicin—pancreatic cancer	0.00063	0.00597	CcSEcCtD
Phenelzine—Oedema—Tamoxifen—pancreatic cancer	0.000621	0.00588	CcSEcCtD
Phenelzine—Delirium—Doxorubicin—pancreatic cancer	0.000616	0.00584	CcSEcCtD
Phenelzine—Oedema—Erlotinib—pancreatic cancer	0.000615	0.00582	CcSEcCtD
Phenelzine—Shock—Erlotinib—pancreatic cancer	0.000605	0.00573	CcSEcCtD
Phenelzine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.0006	0.00569	CcSEcCtD
Phenelzine—Leukopenia—Sunitinib—pancreatic cancer	0.000583	0.00553	CcSEcCtD
Phenelzine—Ataxia—Docetaxel—pancreatic cancer	0.00058	0.00549	CcSEcCtD
Phenelzine—Hepatocellular injury—Epirubicin—pancreatic cancer	0.000573	0.00543	CcSEcCtD
Phenelzine—Convulsion—Sunitinib—pancreatic cancer	0.000565	0.00535	CcSEcCtD
Phenelzine—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.000563	0.00533	CcSEcCtD
Phenelzine—Insomnia—Tamoxifen—pancreatic cancer	0.000562	0.00532	CcSEcCtD
Phenelzine—Paraesthesia—Tamoxifen—pancreatic cancer	0.000558	0.00528	CcSEcCtD
Phenelzine—Insomnia—Erlotinib—pancreatic cancer	0.000556	0.00527	CcSEcCtD
Phenelzine—Dyspepsia—Tamoxifen—pancreatic cancer	0.000547	0.00518	CcSEcCtD
Phenelzine—Dry mouth—Sunitinib—pancreatic cancer	0.000543	0.00514	CcSEcCtD
Phenelzine—Dyspepsia—Erlotinib—pancreatic cancer	0.000541	0.00512	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000536	0.00508	CcSEcCtD
Phenelzine—Fatigue—Tamoxifen—pancreatic cancer	0.000535	0.00507	CcSEcCtD
Phenelzine—Oedema—Sunitinib—pancreatic cancer	0.000532	0.00504	CcSEcCtD
Phenelzine—Constipation—Tamoxifen—pancreatic cancer	0.000531	0.00503	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000531	0.00503	CcSEcCtD
Phenelzine—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.00053	0.00502	CcSEcCtD
Phenelzine—Fatigue—Erlotinib—pancreatic cancer	0.00053	0.00502	CcSEcCtD
Phenelzine—Constipation—Erlotinib—pancreatic cancer	0.000525	0.00498	CcSEcCtD
Phenelzine—Shock—Sunitinib—pancreatic cancer	0.000523	0.00496	CcSEcCtD
Phenelzine—Coma—Epirubicin—pancreatic cancer	0.000523	0.00496	CcSEcCtD
Phenelzine—Hypertonia—Epirubicin—pancreatic cancer	0.000502	0.00476	CcSEcCtD
Phenelzine—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000498	0.00472	CcSEcCtD
Phenelzine—Body temperature increased—Erlotinib—pancreatic cancer	0.000486	0.0046	CcSEcCtD
Phenelzine—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000485	0.0046	CcSEcCtD
Phenelzine—Weight increased—Docetaxel—pancreatic cancer	0.000485	0.00459	CcSEcCtD
Phenelzine—Vision blurred—Fluorouracil—pancreatic cancer	0.000485	0.00459	CcSEcCtD
Phenelzine—Malaise—Irinotecan—pancreatic cancer	0.000484	0.00459	CcSEcCtD
Phenelzine—Coma—Doxorubicin—pancreatic cancer	0.000484	0.00459	CcSEcCtD
Phenelzine—Insomnia—Sunitinib—pancreatic cancer	0.000481	0.00456	CcSEcCtD
Phenelzine—Leukopenia—Irinotecan—pancreatic cancer	0.000481	0.00455	CcSEcCtD
Phenelzine—Paraesthesia—Sunitinib—pancreatic cancer	0.000478	0.00453	CcSEcCtD
Phenelzine—Malaise—Gemcitabine—pancreatic cancer	0.000472	0.00447	CcSEcCtD
Phenelzine—Dyspepsia—Sunitinib—pancreatic cancer	0.000468	0.00444	CcSEcCtD
Phenelzine—Leukopenia—Gemcitabine—pancreatic cancer	0.000468	0.00443	CcSEcCtD
Phenelzine—Hypertonia—Doxorubicin—pancreatic cancer	0.000464	0.0044	CcSEcCtD
Phenelzine—Jaundice—Docetaxel—pancreatic cancer	0.000463	0.00439	CcSEcCtD
Phenelzine—Leukopenia—Fluorouracil—pancreatic cancer	0.00046	0.00436	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000459	0.00435	CcSEcCtD
Phenelzine—Fatigue—Sunitinib—pancreatic cancer	0.000459	0.00434	CcSEcCtD
Phenelzine—Constipation—Sunitinib—pancreatic cancer	0.000455	0.00431	CcSEcCtD
Phenelzine—Discomfort—Irinotecan—pancreatic cancer	0.000452	0.00428	CcSEcCtD
Phenelzine—Asthenia—Tamoxifen—pancreatic cancer	0.000446	0.00422	CcSEcCtD
Phenelzine—Convulsion—Fluorouracil—pancreatic cancer	0.000446	0.00422	CcSEcCtD
Phenelzine—Asthenia—Erlotinib—pancreatic cancer	0.000441	0.00418	CcSEcCtD
Phenelzine—Discomfort—Gemcitabine—pancreatic cancer	0.00044	0.00417	CcSEcCtD
Phenelzine—Pruritus—Tamoxifen—pancreatic cancer	0.000439	0.00416	CcSEcCtD
Phenelzine—Oedema—Irinotecan—pancreatic cancer	0.000438	0.00415	CcSEcCtD
Phenelzine—Pruritus—Erlotinib—pancreatic cancer	0.000435	0.00412	CcSEcCtD
Phenelzine—Discomfort—Fluorouracil—pancreatic cancer	0.000433	0.0041	CcSEcCtD
Phenelzine—Shock—Irinotecan—pancreatic cancer	0.000431	0.00408	CcSEcCtD
Phenelzine—Oedema—Gemcitabine—pancreatic cancer	0.000427	0.00404	CcSEcCtD
Phenelzine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000424	0.00401	CcSEcCtD
Phenelzine—Body temperature increased—Sunitinib—pancreatic cancer	0.000421	0.00398	CcSEcCtD
Phenelzine—Oedema—Fluorouracil—pancreatic cancer	0.00042	0.00398	CcSEcCtD
Phenelzine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000413	0.00391	CcSEcCtD
Phenelzine—Dizziness—Tamoxifen—pancreatic cancer	0.000411	0.00389	CcSEcCtD
Phenelzine—Tachycardia—Fluorouracil—pancreatic cancer	0.00041	0.00388	CcSEcCtD
Phenelzine—Dizziness—Erlotinib—pancreatic cancer	0.000406	0.00385	CcSEcCtD
Phenelzine—Insomnia—Irinotecan—pancreatic cancer	0.000396	0.00375	CcSEcCtD
Phenelzine—Vomiting—Tamoxifen—pancreatic cancer	0.000395	0.00374	CcSEcCtD
Phenelzine—Paraesthesia—Irinotecan—pancreatic cancer	0.000393	0.00373	CcSEcCtD
Phenelzine—Rash—Tamoxifen—pancreatic cancer	0.000392	0.00371	CcSEcCtD
Phenelzine—Dermatitis—Tamoxifen—pancreatic cancer	0.000391	0.00371	CcSEcCtD
Phenelzine—Ataxia—Epirubicin—pancreatic cancer	0.000391	0.0037	CcSEcCtD
Phenelzine—Vomiting—Erlotinib—pancreatic cancer	0.000391	0.0037	CcSEcCtD
Phenelzine—Somnolence—Irinotecan—pancreatic cancer	0.00039	0.00369	CcSEcCtD
Phenelzine—Headache—Tamoxifen—pancreatic cancer	0.000389	0.00369	CcSEcCtD
Phenelzine—Rash—Erlotinib—pancreatic cancer	0.000387	0.00367	CcSEcCtD
Phenelzine—Dermatitis—Erlotinib—pancreatic cancer	0.000387	0.00367	CcSEcCtD
Phenelzine—Insomnia—Gemcitabine—pancreatic cancer	0.000386	0.00366	CcSEcCtD
Phenelzine—Dyspepsia—Irinotecan—pancreatic cancer	0.000386	0.00365	CcSEcCtD
Phenelzine—Headache—Erlotinib—pancreatic cancer	0.000385	0.00365	CcSEcCtD
Phenelzine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000383	0.00363	CcSEcCtD
Phenelzine—Asthenia—Sunitinib—pancreatic cancer	0.000382	0.00362	CcSEcCtD
Phenelzine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00038	0.0036	CcSEcCtD
Phenelzine—Insomnia—Fluorouracil—pancreatic cancer	0.00038	0.0036	CcSEcCtD
Phenelzine—Somnolence—Gemcitabine—pancreatic cancer	0.000379	0.00359	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000378	0.00358	CcSEcCtD
Phenelzine—Fatigue—Irinotecan—pancreatic cancer	0.000378	0.00358	CcSEcCtD
Phenelzine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000377	0.00357	CcSEcCtD
Phenelzine—Pruritus—Sunitinib—pancreatic cancer	0.000376	0.00357	CcSEcCtD
Phenelzine—Constipation—Irinotecan—pancreatic cancer	0.000375	0.00355	CcSEcCtD
Phenelzine—Somnolence—Fluorouracil—pancreatic cancer	0.000373	0.00353	CcSEcCtD
Phenelzine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000369	0.0035	CcSEcCtD
Phenelzine—Nausea—Tamoxifen—pancreatic cancer	0.000369	0.00349	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000369	0.00349	CcSEcCtD
Phenelzine—Fatigue—Gemcitabine—pancreatic cancer	0.000368	0.00349	CcSEcCtD
Phenelzine—Constipation—Gemcitabine—pancreatic cancer	0.000365	0.00346	CcSEcCtD
Phenelzine—Nausea—Erlotinib—pancreatic cancer	0.000365	0.00346	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000362	0.00343	CcSEcCtD
Phenelzine—Ataxia—Doxorubicin—pancreatic cancer	0.000362	0.00343	CcSEcCtD
Phenelzine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000361	0.00342	CcSEcCtD
Phenelzine—Dizziness—Sunitinib—pancreatic cancer	0.000352	0.00333	CcSEcCtD
Phenelzine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000352	0.00333	CcSEcCtD
Phenelzine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000351	0.00333	CcSEcCtD
Phenelzine—Body temperature increased—Irinotecan—pancreatic cancer	0.000346	0.00328	CcSEcCtD
Phenelzine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000346	0.00328	CcSEcCtD
Phenelzine—Vomiting—Sunitinib—pancreatic cancer	0.000338	0.0032	CcSEcCtD
Phenelzine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000337	0.0032	CcSEcCtD
Phenelzine—Rash—Sunitinib—pancreatic cancer	0.000335	0.00318	CcSEcCtD
Phenelzine—Dermatitis—Sunitinib—pancreatic cancer	0.000335	0.00317	CcSEcCtD
Phenelzine—Headache—Sunitinib—pancreatic cancer	0.000333	0.00316	CcSEcCtD
Phenelzine—Leukopenia—Docetaxel—pancreatic cancer	0.000332	0.00315	CcSEcCtD
Phenelzine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000332	0.00314	CcSEcCtD
Phenelzine—Weight increased—Epirubicin—pancreatic cancer	0.000327	0.0031	CcSEcCtD
Phenelzine—Convulsion—Docetaxel—pancreatic cancer	0.000322	0.00305	CcSEcCtD
Phenelzine—Drowsiness—Epirubicin—pancreatic cancer	0.00032	0.00303	CcSEcCtD
Phenelzine—Nausea—Sunitinib—pancreatic cancer	0.000316	0.00299	CcSEcCtD
Phenelzine—Asthenia—Irinotecan—pancreatic cancer	0.000314	0.00298	CcSEcCtD
Phenelzine—Jaundice—Epirubicin—pancreatic cancer	0.000312	0.00296	CcSEcCtD
Phenelzine—Dry mouth—Docetaxel—pancreatic cancer	0.000309	0.00293	CcSEcCtD
Phenelzine—Sweating—Epirubicin—pancreatic cancer	0.000307	0.00291	CcSEcCtD
Phenelzine—Asthenia—Gemcitabine—pancreatic cancer	0.000306	0.0029	CcSEcCtD
Phenelzine—Oedema—Docetaxel—pancreatic cancer	0.000303	0.00287	CcSEcCtD
Phenelzine—Weight increased—Doxorubicin—pancreatic cancer	0.000303	0.00287	CcSEcCtD
Phenelzine—Pruritus—Gemcitabine—pancreatic cancer	0.000302	0.00286	CcSEcCtD
Phenelzine—Shock—Docetaxel—pancreatic cancer	0.000298	0.00282	CcSEcCtD
Phenelzine—Pruritus—Fluorouracil—pancreatic cancer	0.000297	0.00281	CcSEcCtD
Phenelzine—Drowsiness—Doxorubicin—pancreatic cancer	0.000296	0.00281	CcSEcCtD
Phenelzine—Tachycardia—Docetaxel—pancreatic cancer	0.000296	0.0028	CcSEcCtD
Phenelzine—Dizziness—Irinotecan—pancreatic cancer	0.00029	0.00274	CcSEcCtD
Phenelzine—Jaundice—Doxorubicin—pancreatic cancer	0.000289	0.00274	CcSEcCtD
Phenelzine—Sweating—Doxorubicin—pancreatic cancer	0.000284	0.00269	CcSEcCtD
Phenelzine—Vomiting—Irinotecan—pancreatic cancer	0.000279	0.00264	CcSEcCtD
Phenelzine—Dizziness—Fluorouracil—pancreatic cancer	0.000278	0.00263	CcSEcCtD
Phenelzine—Rash—Irinotecan—pancreatic cancer	0.000276	0.00262	CcSEcCtD
Phenelzine—Dermatitis—Irinotecan—pancreatic cancer	0.000276	0.00261	CcSEcCtD
Phenelzine—Headache—Irinotecan—pancreatic cancer	0.000275	0.0026	CcSEcCtD
Phenelzine—Insomnia—Docetaxel—pancreatic cancer	0.000274	0.0026	CcSEcCtD
Phenelzine—Paraesthesia—Docetaxel—pancreatic cancer	0.000272	0.00258	CcSEcCtD
Phenelzine—Vomiting—Gemcitabine—pancreatic cancer	0.000271	0.00257	CcSEcCtD
Phenelzine—Somnolence—Docetaxel—pancreatic cancer	0.000269	0.00255	CcSEcCtD
Phenelzine—Rash—Gemcitabine—pancreatic cancer	0.000269	0.00255	CcSEcCtD
Phenelzine—Dermatitis—Gemcitabine—pancreatic cancer	0.000269	0.00255	CcSEcCtD
Phenelzine—Headache—Gemcitabine—pancreatic cancer	0.000267	0.00253	CcSEcCtD
Phenelzine—Vomiting—Fluorouracil—pancreatic cancer	0.000267	0.00253	CcSEcCtD
Phenelzine—Dyspepsia—Docetaxel—pancreatic cancer	0.000267	0.00253	CcSEcCtD
Phenelzine—Rash—Fluorouracil—pancreatic cancer	0.000265	0.00251	CcSEcCtD
Phenelzine—Dermatitis—Fluorouracil—pancreatic cancer	0.000264	0.0025	CcSEcCtD
Phenelzine—Headache—Fluorouracil—pancreatic cancer	0.000263	0.00249	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000262	0.00248	CcSEcCtD
Phenelzine—Fatigue—Docetaxel—pancreatic cancer	0.000261	0.00247	CcSEcCtD
Phenelzine—Nausea—Irinotecan—pancreatic cancer	0.00026	0.00247	CcSEcCtD
Phenelzine—Constipation—Docetaxel—pancreatic cancer	0.000259	0.00245	CcSEcCtD
Phenelzine—Nausea—Gemcitabine—pancreatic cancer	0.000254	0.0024	CcSEcCtD
Phenelzine—Feeling abnormal—Docetaxel—pancreatic cancer	0.00025	0.00236	CcSEcCtD
Phenelzine—Nausea—Fluorouracil—pancreatic cancer	0.000249	0.00236	CcSEcCtD
Phenelzine—Nervousness—Epirubicin—pancreatic cancer	0.000243	0.0023	CcSEcCtD
Phenelzine—Body temperature increased—Docetaxel—pancreatic cancer	0.000239	0.00227	CcSEcCtD
Phenelzine—Vision blurred—Epirubicin—pancreatic cancer	0.000236	0.00223	CcSEcCtD
Phenelzine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000232	0.0022	CcSEcCtD
Phenelzine—Agitation—Epirubicin—pancreatic cancer	0.00023	0.00218	CcSEcCtD
Phenelzine—Malaise—Epirubicin—pancreatic cancer	0.000226	0.00214	CcSEcCtD
Phenelzine—Nervousness—Doxorubicin—pancreatic cancer	0.000225	0.00213	CcSEcCtD
Phenelzine—Leukopenia—Epirubicin—pancreatic cancer	0.000224	0.00212	CcSEcCtD
Phenelzine—Vision blurred—Doxorubicin—pancreatic cancer	0.000218	0.00207	CcSEcCtD
Phenelzine—Asthenia—Docetaxel—pancreatic cancer	0.000217	0.00206	CcSEcCtD
Phenelzine—Convulsion—Epirubicin—pancreatic cancer	0.000217	0.00205	CcSEcCtD
Phenelzine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000215	0.00204	CcSEcCtD
Phenelzine—Pruritus—Docetaxel—pancreatic cancer	0.000214	0.00203	CcSEcCtD
Phenelzine—Agitation—Doxorubicin—pancreatic cancer	0.000213	0.00202	CcSEcCtD
Phenelzine—Anxiety—Epirubicin—pancreatic cancer	0.000212	0.00201	CcSEcCtD
Phenelzine—Discomfort—Epirubicin—pancreatic cancer	0.000211	0.00199	CcSEcCtD
Phenelzine—Malaise—Doxorubicin—pancreatic cancer	0.000209	0.00198	CcSEcCtD
Phenelzine—Dry mouth—Epirubicin—pancreatic cancer	0.000208	0.00197	CcSEcCtD
Phenelzine—Leukopenia—Doxorubicin—pancreatic cancer	0.000207	0.00196	CcSEcCtD
Phenelzine—Oedema—Epirubicin—pancreatic cancer	0.000204	0.00194	CcSEcCtD
Phenelzine—Shock—Epirubicin—pancreatic cancer	0.000201	0.0019	CcSEcCtD
Phenelzine—Convulsion—Doxorubicin—pancreatic cancer	0.000201	0.0019	CcSEcCtD
Phenelzine—Dizziness—Docetaxel—pancreatic cancer	0.0002	0.0019	CcSEcCtD
Phenelzine—Tachycardia—Epirubicin—pancreatic cancer	0.000199	0.00189	CcSEcCtD
Phenelzine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000198	0.00187	CcSEcCtD
Phenelzine—Anxiety—Doxorubicin—pancreatic cancer	0.000197	0.00186	CcSEcCtD
Phenelzine—Discomfort—Doxorubicin—pancreatic cancer	0.000195	0.00185	CcSEcCtD
Phenelzine—Dry mouth—Doxorubicin—pancreatic cancer	0.000193	0.00183	CcSEcCtD
Phenelzine—Vomiting—Docetaxel—pancreatic cancer	0.000193	0.00182	CcSEcCtD
Phenelzine—Rash—Docetaxel—pancreatic cancer	0.000191	0.00181	CcSEcCtD
Phenelzine—Dermatitis—Docetaxel—pancreatic cancer	0.000191	0.00181	CcSEcCtD
Phenelzine—Headache—Docetaxel—pancreatic cancer	0.00019	0.0018	CcSEcCtD
Phenelzine—Oedema—Doxorubicin—pancreatic cancer	0.000189	0.00179	CcSEcCtD
Phenelzine—Shock—Doxorubicin—pancreatic cancer	0.000186	0.00176	CcSEcCtD
Phenelzine—Insomnia—Epirubicin—pancreatic cancer	0.000185	0.00175	CcSEcCtD
Phenelzine—Tachycardia—Doxorubicin—pancreatic cancer	0.000185	0.00175	CcSEcCtD
Phenelzine—Paraesthesia—Epirubicin—pancreatic cancer	0.000183	0.00174	CcSEcCtD
Phenelzine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000183	0.00173	CcSEcCtD
Phenelzine—Somnolence—Epirubicin—pancreatic cancer	0.000182	0.00172	CcSEcCtD
Phenelzine—Nausea—Docetaxel—pancreatic cancer	0.00018	0.0017	CcSEcCtD
Phenelzine—Dyspepsia—Epirubicin—pancreatic cancer	0.00018	0.0017	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000176	0.00167	CcSEcCtD
Phenelzine—Fatigue—Epirubicin—pancreatic cancer	0.000176	0.00167	CcSEcCtD
Phenelzine—Constipation—Epirubicin—pancreatic cancer	0.000175	0.00166	CcSEcCtD
Phenelzine—Insomnia—Doxorubicin—pancreatic cancer	0.000171	0.00162	CcSEcCtD
Phenelzine—Paraesthesia—Doxorubicin—pancreatic cancer	0.00017	0.00161	CcSEcCtD
Phenelzine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000168	0.00159	CcSEcCtD
Phenelzine—Somnolence—Doxorubicin—pancreatic cancer	0.000168	0.00159	CcSEcCtD
Phenelzine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000166	0.00158	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000163	0.00155	CcSEcCtD
Phenelzine—Fatigue—Doxorubicin—pancreatic cancer	0.000163	0.00154	CcSEcCtD
Phenelzine—Constipation—Doxorubicin—pancreatic cancer	0.000162	0.00153	CcSEcCtD
Phenelzine—Body temperature increased—Epirubicin—pancreatic cancer	0.000162	0.00153	CcSEcCtD
Phenelzine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000156	0.00148	CcSEcCtD
Phenelzine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000149	0.00142	CcSEcCtD
Phenelzine—Asthenia—Epirubicin—pancreatic cancer	0.000147	0.00139	CcSEcCtD
Phenelzine—Pruritus—Epirubicin—pancreatic cancer	0.000145	0.00137	CcSEcCtD
Phenelzine—Asthenia—Doxorubicin—pancreatic cancer	0.000136	0.00128	CcSEcCtD
Phenelzine—Dizziness—Epirubicin—pancreatic cancer	0.000135	0.00128	CcSEcCtD
Phenelzine—Pruritus—Doxorubicin—pancreatic cancer	0.000134	0.00127	CcSEcCtD
Phenelzine—Vomiting—Epirubicin—pancreatic cancer	0.00013	0.00123	CcSEcCtD
Phenelzine—Rash—Epirubicin—pancreatic cancer	0.000129	0.00122	CcSEcCtD
Phenelzine—Dermatitis—Epirubicin—pancreatic cancer	0.000129	0.00122	CcSEcCtD
Phenelzine—Headache—Epirubicin—pancreatic cancer	0.000128	0.00121	CcSEcCtD
Phenelzine—Dizziness—Doxorubicin—pancreatic cancer	0.000125	0.00118	CcSEcCtD
Phenelzine—Nausea—Epirubicin—pancreatic cancer	0.000121	0.00115	CcSEcCtD
Phenelzine—Vomiting—Doxorubicin—pancreatic cancer	0.00012	0.00114	CcSEcCtD
Phenelzine—Rash—Doxorubicin—pancreatic cancer	0.000119	0.00113	CcSEcCtD
Phenelzine—Dermatitis—Doxorubicin—pancreatic cancer	0.000119	0.00113	CcSEcCtD
Phenelzine—Headache—Doxorubicin—pancreatic cancer	0.000118	0.00112	CcSEcCtD
Phenelzine—Nausea—Doxorubicin—pancreatic cancer	0.000112	0.00106	CcSEcCtD
